Clinical Trial Update: Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a short-course hypofractionated radiotherapy regimen for localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Alberta Health services | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED